David Louis

David Louis, MD serves as Pathologist-in-Chief at Massachusetts General Hospital and holds the Benjamin Castleman Professorship in Pathology at Harvard Medical School. His clinical expertise spans neuropathology with specialization in frozen section pathology and molecular diagnostics for adult patients.

Dr. Louis's research focuses on the molecular characterization and classification of central nervous system tumors, particularly glioblastomas. His work has been instrumental in developing standardized diagnostic criteria through successive editions of the WHO Classification of Tumors of the Central Nervous System. He has pioneered the application of single-cell RNA sequencing to uncover tumor heterogeneity and cellular states in brain cancers, with particular emphasis on H3K27M-mutant gliomas and immune microenvironment interactions.

Analysis of Dr. Louis's publication history reveals a consistent trajectory from traditional histopathology toward cutting-edge genomic approaches. His work bridges clinical neuropathology with basic science, translating molecular discoveries into improved diagnostic frameworks. The WHO classification papers represent landmark contributions that have standardized brain tumor diagnosis worldwide, while his single-cell studies have revealed new biological insights about tumor plasticity and evolution.

Scientific Recognition:

• Mass General History Award: Celebrating 'Keen Minds' (2020)

As Pathologist-in-Chief at one of America's premier medical institutions, Dr. Louis oversees a comprehensive pathology service while maintaining an active research program. His leadership extends to national and international neuropathology organizations where he has shaped diagnostic standards and research directions. Though specific mentoring details aren't provided in available materials, his extensive publication record with numerous trainees suggests significant academic mentorship.

Dr. Louis's work occurs at the intersection of clinical neuropathology and molecular oncology, with his laboratory contributing to the MGH Research Institute - recognized as the largest hospital-based research program in the United States with over 8,500 researchers across 30 departments and institutes.